In vivo footprinting analysis of the Glypican 3 (GPC3) promoter region in neuroblastoma cells

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1769, Issue 3, 2007, Pages 182-193

  Boily, Gino ^a   Ouellet, Stéphane ^b   Langlois, Sylvie ^a   Larivière, Mathieu ^a   Drouin, Régen ^b   Sinnett, Daniel ^a,c  

^a Research Center   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

GPC3; In vivo footprinting; Neuroblastoma; Transcription factor

Indexed keywords

DIMETHYL SULFATE; GLYPICAN 3; NUCLEAR FACTOR Y; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL TYPE; CHROMATIN IMMUNOPRECIPITATION; COMPLEX FORMATION; DNA FOOTPRINTING; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; IN VIVO STUDY; MALE; NEPHROBLASTOMA; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOSOME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; TRANSCRIPTION REGULATION; ULTRAVIOLET IRRADIATION;

BASE SEQUENCE; CHROMATIN IMMUNOPRECIPITATION; DNA FOOTPRINTING; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYPICANS; HUMANS; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

EID: 34047137057     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbaexp.2007.01.014     Document Type: Article

References (31)

1. Saikali Z., and Sinnett D. Expression of glypican 3 (GPC3) in embryonal tumors. Int. J. Cancer 89 (2000) 418-422
2. Toretsky J.A., Zitomersky N.L., Eskenazi A.E., Voigt R.W., Strauch E.D., Sun C.C., Huber R., Meltzer S.J., and Schlessinger D. Glypican-3 expression in Wilms tumor and hepatoblastoma. J. Pediatr. Hematol./Oncol. 23 (2001) 496-499
3. Filmus J., Church J.G., and Buick R.N. Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine. Mol. Cell. Biol. 8 (1988) 4243-4249
4. Hsu H.C., Cheng W., and Lai P.L. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution. Cancer Res. 57 (1997) 5179-5184
5. Pellegrini M., Pilia G., Pantano S., Lucchini F., Uda M., Fumi M., Cao A., Schlessinger D., and Forabosco A. Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome. Dev. Dyn. 213 (1998) 431-439
6. Huber R., Crisponi L., Mazzarella R., Chen C.N., Su Y., Shizuya H., Chen E.Y., Cao A., and Pilia G. Analysis of exon/intron structure and 400 kb of genomic sequence surrounding the 5′-promoter and 3′-terminal ends of the human glypican 3 (GPC3) gene. Genomics 45 (1997) 48-58
7. Pilia G., Hughes-Benzie R.M., MacKenzie A., Baybayan P., Chen E.Y., Huber R., Neri G., Cao A., Forabosco A., and Schlessinger D. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat. Genet. 12 (1996) 241-247
8. Cano-Gauci D.F., Song H.H., Yang H., McKerlie C., Choo B., Shi W., Pullano R., Piscione T.D., Grisaru S., Soon S., Sedlackova L., Tanswell A.K., Mak T.W., Yeger H., Lockwood G.A., Rosenblum N.D., and Filmus J. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome. J. Cell Biol. 146 (1999) 255-264
9. Lin H., Huber R., Schlessinger D., and Morin P.J. Frequent silencing of the GPC3 gene in ovarian cancer cell lines. Cancer Res. 59 (1999) 807-810
10. Murthy S.S., Shen T., De Rienzo A., Lee W.C., Ferriola P.C., Jhanwar S.C., Mossman B.T., Filmus J., and Testa J.R. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma. Oncogene 19 (2000) 410-416
11. Weksberg R., Squire J.A., and Templeton D.M. Glypicans: a growing trend. Nat. Genet. 12 (1996) 225-227
12. Xiang Y.Y., Ladeda V., and Filmus J. Glypican-3 expression is silenced in human breast cancer. Oncogene 20 (2001) 7408-7412
13. Midorikawa Y., Ishikawa S., Iwanari H., Imamura T., Sakamoto H., Miyazono K., Kodama T., Makuuchi M., and Aburatani H. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int. J. Cancer 103 (2003) 455-465
14. Zhu Z.W., Friess H., Wang L., Abou-Shady M., Zimmermann A., Lander A.D., Korc M., Kleeff J., and Buchler M.W. Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders. Gut 48 (2001) 558-564
15. Lage H., Dietel M., Froschle G., and Reymann A. Expression of the novel mitoxantrone resistance associated gene MXR7 in colorectal malignancies. Int. J. Clin. Pharmacol. Ther. 36 (1998) 58-60
16. Filmus J. Glypicans in growth control and cancer. Glycobiology 11 (2001) 19R-23R
17. Boily G., Saikali Z., and Sinnett D. Methylation analysis of the glypican 3 gene in embryonal tumours. Br. J. Cancer 90 (2004) 1606-1611
18. Huber R., Schlessinger D., and Pilia G. Multiple Sp1 sites efficiently drive transcription of the TATA-less promoter of the human glypican 3 (GPC3) gene. Gene 214 (1998) 35-44
19. Drouin R., Therrien J.P., Angers M., and Ouellet S. In vivo DNA analysis. Methods Mol. Biol. 148 (2001) 175-219
20. Maxam A.M., and Gilbert W. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 65 (1980) 499-560
21. Drouin R., Gao S., and Holmquist G.P. Agarose gel electrophoresis for DNA damage analysis. In: Pfeifer G.P. (Ed). Technologies for Detection of DNA Damage and Mutations (1996), Plenum Press, New York 37-43
22. Pfeifer G.P., and Riggs A.D. Genomic sequencing. In: Griffin G.H., and Griffin A.M. (Eds). Methods in Molecular Biology (1993), Humana Press Inc., Toyowa, NJ 169-181
23. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 (1983) 1475-1489
24. Gale J.M., Nissen K.A., and Smerdon M.J. UV-induced formation of pyrimidine dimers in nucleosome core DNA is strongly modulated with a period of 10.3 bases. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 6644-6648
25. Tornaletti S., Bates S., and Pfeifer G.P. A high-resolution analysis of chromatin structure along p53 sequences. Mol. Carcinog. 17 (1996) 192-201
26. Chin P.L., Momand J., and Pfeifer G.P. In vivo evidence for binding of p53 to consensus binding sites in the p21 and GADD45 genes in response to ionizing radiation. Oncogene 15 (1997) 87-99
27. McGhee J.D., and Felsenfeld G. Reaction of nucleosome DNA with dimethyl sulfate. Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 2133-2137
28. Quandt K., Frech K., Karas H., Wingender E., and Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23 (1995) 4878-4884
29. Zhang Z., and Gerstein M. Of mice and men: phylogenetic footprinting aids the discovery of regulatory elements. J. Biol. 2 (2003) 11
30. Mantovani R. A survey of 178 NF-Y binding CCAAT boxes. Nucleic Acids Res. 26 (1998) 1135-1143
31. Pugh B.F., and Tjian R. Transcription from a TATA-less promoter requires a multisubunit TFIID complex. Genes Dev. 5 (1991) 1935-1945